Skip to content
2000
Volume 11, Issue 8
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

MicroRNA-21 (miR-21) expression is activated in multiple types of cancers, such as breast, liver, brain, prostate, myometrial cancers but also in cardiovascular disease. MiR-21 regulates a plethora of target proteins which are involved in cellular survival, apoptosis and cell invasiveness. MiR-21 regulation is complex due to an own promoter that is target for various transcription factors and hormones. The consistent miR-21 overexpression under pathophysiological conditions points to miR-21 as a valuable tool for new therapeutic strategies. In this review, we present and analyze current data about miR-21 expression in various pathologies ranging from cancer to cardiovascular disease. Further, miR- 21 regulatory mechanisms and miR-21 downstream targets are discussed. Finally, we highlight the particular role of miR- 21 as a therapeutic target in various diseases.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945010791591403
2010-08-01
2025-05-03
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945010791591403
Loading

  • Article Type:
    Research Article
Keyword(s): cancer; cardiovascular disease; micro-RNAs; miR-21
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test